Skip to main content
Search hero banner

Search results

Showing 681 - 700 of 770 results

Chronic Kidney disease of unknown origin

Chronic kidney disease of unknown origin

In 2017, ANSTO's CEO signed a Memorandum of Understanding with Sri Lanka to work together to investigate the epidemiology of Chronic Kidney Disease of unknown origin (CKDu).

After your experiment clayton

After your experiment

Following your experiment at the Australian Synchrotron there are certain tasks that users can complete including a user feedback survey and claiming reimbursement for travel expenses.

Dr Kathleen Riches
Quality and Risk Manager

Kathleen manages the quality and document management systems, and oversees procedures for inspection, testing, and calibration of equipment and systems, to support the accelerator operations and beam lines.

High Performance Macromolecular Crystallography Beamline (MX3)

High Performance Macromolecular Crystallography Beamline (MX3)

The High Performance Macromolecular Crystallography beamline will enable the study of very small (sub-5 micrometre) or weakly diffracting crystals, providing a state-of-the-art high-throughput facility for researchers. MX3 will be able to study the structures of large proteins and protein complexes for virology, drug design and industrial applications via goniometer mounted crystals, in-tray screening, or via serial crystallography methods.

Dr Daryl Howard
Senior Scientist - X-ray Fluorescence Microscopy

Role at ANSTO

Pagination